Melanoma


Large congenital nevus. (With permission from Mulholland MW, Lillemoe KD, Doherty GM, Maier RV, Upchurch GR, eds. Greenfield’s Surgery. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005.)


Congenital Nevi


1% of children are born with congenital nevi


Lifetime risk of progression from congenital nevus to melanoma is dependent on the lesion’s size


Classified as small <1.5 cm, medium-sized 1.5 to 20 cm, and large >20 cm


Lesions <1.5 cm have a less than 1% chance of progressing to melanoma


Lesions >20 cm have a 4.5% to 10% lifetime risk of progressing to melanoma


Many of these will develop into melanoma in the first few years of life and therefore early excision is warranted


There is a spectrum of management strategies for congenital nevi based on size: large lesions (greater than 20 cm) should be excised early in life, while small lesions (less than 1.5 cm in size) have a minimal chance of progression and should be carefully observed.


A 45-year-old male has a 1.5-mm-thick melanoma on his right arm, without any axillary lymphadenopathy or abnormalities on chest X-ray. His liver function tests are normal. CT scans of the abdomen and pelvis are obtained and are negative for any distant metastases. What is this patient’s TNM classification?


This patient’s lesion has an American Joint Committee on Cancer (AJCC) TNM classification of T2, N0, M0.


Melanoma TNM Classification


Based on the American Joint Committee on Cancer (AJCC) classification


Tumor (T)


T1 = Depth of 1 mm or less


For T1 lesions, T status is further designated “a” or “b” based on < or ≥ 1 mitosis/mm2


T2 = 1 to 2 mm


T3 = 2 to 4 mm


T4 = >4 mm


For all lesions, T status is further designated “a” or “b” based on ulcerated or non-ulcerated


Node (N)


N0 = No affected nodes


N1 = One affected node


T status is further designated “a” or “b” based on micro- or macrometastases


N2 = Two or three nodes or in-transit lesion with negative LNs


T status is further designated “a,” “b,” or “c” based on micro- or macrometastases, or in-transit lesion with negative LNs


N3 = Four or more nodes; matted LNs or in-transit lesion with positive LNs


Metastasis (M)


M0 = No metastases


M1a = Distant skin or distant lymph node metastases


M1b = Any lung metastases


M1c = All other visceral metastases or distant metastases, or any patient with any metastases with an elevated LDH


Further subdivisions exist based on metastasis size


A 50-year-old male with a 2-mm-thick melanoma on his leg has two enlarged inguinal lymph nodes. A chest X-ray is normal. What is his clinical stage?


This patient’s lesion has an American Joint Committee on Cancer (AJCC) TNM classification of T2, N2, M0, which is classified as clinical stage III.


Melanoma Staging


Based on TNM classification of disease


Staging should be used following complete excision of the primary melanoma and clinical and radiologic evaluation for metastases


Stage 0: in situ disease only


Stage I: T1 or T2; no nodal disease


Stage II: T2 with ulceration, or T3 or T4; no nodal disease


Stage III: Any nodal disease


Stage IV: Any metastatic disease


Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 20, 2017 | Posted by in GENERAL & FAMILY MEDICINE | Comments Off on Melanoma

Full access? Get Clinical Tree

Get Clinical Tree app for offline access